IL6 and cancer: With respect to the tumor microenvironment, it has been shown that cancer-associated fibroblasts and pro-tumorigenic macrophages secrete IL-6 that triggers STAT3 activation in CRC cells, and this leads to an increase in RAC1B expression in the cancer cells [97].